Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Walgreens (WBA) May Buy Remaining Stake In AmerisourceBergen

Published 02/12/2018, 10:26 PM
Updated 07/09/2023, 06:31 AM

Per a report in The Wall Street Journal, Walgreens Boots Alliance, Inc. (NASDAQ:WBA) is in early-stage talks to buy the remaining stake in the leading pharmaceutical services company, AmerisourceBergen Corporation (NYSE:ABC) . Soon after the takeover rumor surfaced on Feb 12, shares of AmerisourceBergen gained 15.7% in after-hours trading and subsequently, closed with a 0.3% rise. However, the stock price of Walgreens remained unchanged.

In this regard, we remind investors that the drugstore retailer and pharmacy-led, health and wellbeing enterprise already holds a 26% stake in AmerisourceBergen, which is part of their long-term strategic relationship, formed in 2013. That relationship comprises a 10-year pharmaceutical distribution contract with AmerisourceBergen.

We believe, Walgreen’s latest decision to acquire AmerisourceBergen’s remaining stake, comes close on the heels of its rival CVS Health’s (NYSE:CVS) gigantic $69-billion acquisition deal of health insurer, Aetna Inc (NYSE:AET) . According to a Reuters report, the Walgreens-AmerisourceBergen integration, similar to the CVS-Aetna deal, is likely to move toward a vertical consolidation, combining all members of a supply chain.

This apart, some analysts believe that this move may be in response to Amazon’s latest decision to step into the multibillion-dollar pharmaceutical industry. Notably, in December 2017, Amazon.com, Inc (NASDAQ:AMZN) had acquired pharmacy licenses in a dozen states.

As far as the news revolving around Walgreens-AmerisourceBergen agreement is concerned, many market researchers view this takeover rumor to be strategic, although the companies themselves have remained silent on this speculative issue.

Significantly, Walgreens has a market capitalization of $67.82 billion while the same for AmerisourceBergen remains at $19.65 billion.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>



Amazon.com, Inc. (AMZN): Free Stock Analysis Report

Aetna Inc. (AET): Free Stock Analysis Report

CVS Health Corporation (CVS): Free Stock Analysis Report

Walgreens Boots Alliance, Inc. (WBA): Free Stock Analysis Report

AmerisourceBergen Corporation (Holding Co) (ABC): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.